<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Mon, 20 Apr 2026 10:01:27 -0400--><rss version="2.0">
    <channel>
        <title>Sigyn Therapeutics, Inc. (SIGY) SEC Filings</title>
        <link>https://www.sigyntherapeutics.com/investors/sec-filings/section-16-filings/rss</link>
        <description>Sigyn Therapeutics, Inc. (SIGY) - Section 16 Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/sigyntherapeutics/files/theme/images/logo-sm.png</url>
                <title>Sigyn Therapeutics, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[4/A - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4/A]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-17-003390/0001615774-17-003390.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:28:15 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-17-003390/0001615774-17-003390.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-17-003338/0001615774-17-003338.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:28:12 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-17-003338/0001615774-17-003338.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-17-001323/0001615774-17-001323.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:24:26 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-17-001323/0001615774-17-001323.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-008984/0001615774-16-008984.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:24:12 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-008984/0001615774-16-008984.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-008928/0001615774-16-008928.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:24:10 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-008928/0001615774-16-008928.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[3 - Initial statement of beneficial ownership of securities]]></title>
                <description><![CDATA[3]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-004139/0001615774-16-004139.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:17:56 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-004139/0001615774-16-004139.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[3 - Initial statement of beneficial ownership of securities]]></title>
                <description><![CDATA[3]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-004138/0001615774-16-004138.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:17:54 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-004138/0001615774-16-004138.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[3 - Initial statement of beneficial ownership of securities]]></title>
                <description><![CDATA[3]]></description>
                <link>https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-004009/0001615774-16-004009.pdf</link>
                <pubDate>Tue, 20 Oct 20 10:17:47 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/investors/sec-filings/all-sec-filings/content/0001615774-16-004009/0001615774-16-004009.pdf</guid>
                                                                            </item>
            </channel>
</rss>